Analytical Data
-
Gene name
BTBD11
- Application
-
Alternative Names
BTBD11; Ankyrin repeat and BTB/POZ domain-containing protein BTBD11; BTB/POZ domain-containing protein 11
-
Species
Human
-
Source
Baculovirus
-
Tag
N-StrepⅡ;N-8*His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
A6QL63
-
Expression Region
A2-V1104
-
Protein Length
Full Length
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
BTBD11, a member of the BTB/POZ domain-containing protein family, has gained attention in recent years due to its potential roles in various biological processes, including gene regulation, protein-protein interactions, and cellular signaling pathways. Research on BTBD11 has uncovered its involvement in the regulation of transcription factors and the modulation of critical cellular functions such as differentiation and stress response. Moreover, significant associations between BTBD11 expression levels and several diseases, including cancer and neurodegenerative disorders, have been reported, highlighting its potential as a therapeutic target. The interest in BTBD11 is further fueled by its unique structural characteristics, which allow for diverse interactions with other proteins, influencing cellular dynamics and responses. As a result, the study of recombinant BTBD11 proteins aims to elucidate their functional mechanisms, interactions, and potential applications in medicine and biotechnology. Understanding the specific roles of BTBD11 in various cellular contexts could provide insights into its contribution to diseases and lead to innovative therapeutic strategies.
